Ophthalmology News

Researchers said a blood test can show when a woman may experience her last menstrual period. This was the top story in endocrinology last week.

Switching to a biosimilar would be a “feasible treatment choice,” and is associated with maintaining clinical efficacy in patients with noninfectious uveitis who previously received the reference biologic, according to data published in Frontiers in Pharmacology.

The FDA has granted breakthrough device designation to the RightEye Vision System, an oculomotor test to help diagnose Parkinson’s disease, RightEye LLC announced in a press release.

The National Institute on Aging has awarded a $17.2 million grant to University of Washington School of Medicine assistant professor of ophthalmology Cecilia Lee, MD, to lead a research team looking to make connections between eye diseases and Alzheimer’s disease.

Susan R. Bailey, MD, an allergist and immunologist based in Fort Worth, Texas, was voted in as president-elect of the AMA at the organization’s 2019 meeting.

The U.S. Preventive Services Task Force gave an ‘A’ level recommendation to prophylactic ocular topical medication to prevent gonococcal ophthalmia neonatorum regardless of a woman’s gestational age, according to a report recently published in JAMA.

Neurologists consider an acute retinal artery obstruction a true medical emergency and classify it as a stroke.

More than half of older patients surveyed said their primary care provider did not ask them about their vision, according to findings recently released from the National Poll on Healthy Aging.

SAN FRANCISCO — In 1993, the CDC recommended routinely screening all pregnant women for Chlamydia trachomatis, or CT, which has significantly reduced the number of neonatal chlamydial conjunctivitis cases in the United States, according to research presented at IDWeek 2018.

The rate of trachoma, or ocular chlamydia, among children living in hyperendemic areas can be stalled with annual or biannual mass azithromycin distribution. However, discontinuing the antibiotic after 4 years led to an increased rate of infection in the pediatric population, according to trial results published in PLoS Medicine.